Vietnam’s national vaccine institute has successfully tested a low-cost bird flu vaccine on humans, saying it will be valuable in case of a global pandemic, should it come.
The Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang announced the test results on Wednesday, naming the vaccine IVACFLU-H5N1.
It conducted tests with the Pasteur Institute in Ho Chi Minh City, with funding from the World Health Organization.
Different doses of the vaccine were given to 75 adults, both male and female, and none of them developed any serious negative reactions, the institute said.
The high dose has proved to be able to protect the body against the bird flu virus strain H5N1, which has killed 65 people in Vietnam, one of the highest fatality rates in the world, since it recurred in 2003.
Le Van Be, director of the institute, said it is conducting further tests so that the vaccine can receive license for industrial production “to provide for domestic and global demands.”
Be said only a small number of producers are providing bird flu vaccines and at the price unaffordable to countries with low or middle income.
IVAC’s product will be a vital solution to that problem, he said.